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Identity 
Other names: FRP-4; sFRP-4; FRPHE; MGC26498; 
LOC6424 
HGNC (Hugo): SFRP4 
Location: 7p14.1 
Local order: According to NCBI, SFRP4 is telomeric 
to EPDR1 (7p14.1) ependymin related protein 1 
(zebrafish) and STARD3NL (7p14-p13) StAR-related 
lipid transfer domain containing 3 N-terminal like and 
centromeric to TXNDC3 (7p14.1) thioredoxin domain 
containing 3 (spermatozoa) and GPR141 (7p14.1) G 
protein-coupled receptor 141. 
DNA/RNA 
Description 
The SFRP4 gene spans 10.99 kb on the short arm of 
chromosome 7 and is transcribed from the minus strand 
in the centromere-to-telomere orientation. The gene is 
encoded by six exons with the trans-lation initiation 
codon in the first exon. 
Transcription 
The SFRP4 mRNA transcript is 2974 bp, 1041 bp are 
coding sequence. Ensembl data predicts a second 
transcript from the SFRP4 gene, lacking the 81 bp exon 
2, although this has not been demons-trated. 
Protein 
Description 
SFRP4 protein is comprised of 346 amino acids with a 
predicted molecular weight of 39.9 kDa and an actual 
molecular weight of approximately 50-55 kDa. 
SFRP4 belongs to a family of five SFRPs; these 
proteins fold into two independent domains. The N-
terminus contains a secretion signal peptide followed 
by a ~120 amino acid cysteine-rich domain (CRD). The 
CRD is 30-50% identical to the extracellular putative 
Wnt-binding domain of frizzled (Fzd) receptors and is 
characterized by the presence of ten cysteine residu  at 
conserved positions. 
 
Diagram illustrates SFRP4 gene that contains a total of six exons. 
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Diagram illustrates the full length SFRP4 protein which contains a signal peptide sequence of 20-30 amino acids, a cysteine-rich domain 
(CRD) of approximately 120 amino acids, and a netrin-related motif (NTR) domain. Conserved cysteines of the CRD are indicated by *. 
 
These cysteines form a pattern of disulfide bridges. The 
C-terminal portion of the SFRP protein is characterized 
by segments of positively charged residues that appe r 
to confer heparin-binding properties in at least two 
SFRPs (SFRP1 and SFRP3) and contains a netrin-
related motif (NTR) with six cysteine residues that 
most likely form three disulfide bridges. NTR domains 
with similar features are found in a wide range of 
unrelated proteins, including Netrin-1, tissue inhibitors 
of metallo-proteinases (TIMPs), complement proteins 
and type I procollagen C-proteinase enhancer proteins 
(PCOLCEs). The six conserved cysteines in the NTR 
of SFRP4 share a similar spacing to SFRP3, whereas 
those of the SFRP1/SFRP2/SFRP5 subgroup are 
distinctively different, indicating a disparity in disulfide 
bond formation. Uniquely, SFRP4 contains two 
additional cysteine residues. The overall function of the 
NTR is unknown, yet there is some evidence that the 
NTR may also play a role in Wnt binding. This implies 
that multiple Wnt binding sites may exist on SFRP 
molecules and/or that SFRPs exhibit differential 
affinities for Wnt ligands according to the different 
SFRP conformational and post-translational 
modifications. 
Expression 
SFRP4 is expressed in various normal tissues including 
endometrium (specifically stromal cells with higher 
expression during proliferative phase of menstrual 
cycle), ovary, kidney, heart, brain, mammary gland, 
cervix, pancreas, stomach, colon, lung, skeletal muscle, 
testis, eye, bone, prostate, and liver. 
Localisation 
Secreted from cell; extracellular matrix; bound to 
plasma membrane. 
Function 
Since SFRPs share a similar CRD with the Fzd family 
of receptors; it is believed that SFRPs may act as 
soluble modulators that compete with Fzd to bind the 
Wnt ligands, thereby altering the Wnt signal. Indivi ual 
SFRPs also have distinct binding specificity for distinct 
Wnt ligands. Reports have demonstrated that SFRP4 
binds Wnt7a and there is conflicting data for SFRP4 
binding to Wnt3a. SFRP4 expression is regulated by 
estrogen and progesterone and may act as a regulator of  
adult uterine morphology and function. SFRP4 has 
been shown to increase apoptosis during ovulation. 
Transgenic studies have found that SFRP4 decreases 
bone formation and inhibits osteoblast proliferation by 
attenuating canonical/beta-catenin-Wnt signaling. 
SFRP4 reportedly exhibits phospha-turic effects by 
specifically inhibiting sodium-dependent phosphate 
uptake. 
Homology 
Of the five human SFRPs (SFRP1, SFRP2, SFRP3, 
SFRP4, SFRP5), SFRP4 shares most significant 
homology with SFRP3. 
Mutations 
Note 
It was reported that the T allele of the SFRP4 gene 
polymorphism ARG262 (CGC to CGT) of exon4 is 
associated with decreased bone mineral density in post-




SFRP4 was more frequently down-regulated in 
(microsatellite instability). MSI cancers as compared 
with (microsatellite stable) MSS endo-metrioid 
endometrial cancers. Expression of SFRP4 is decreased 
in both low-grade endometrial stromal sarcoma and 
undifferentiated endometrial sarcoma. 
Malignant Pleural Mesothelioma 
Note 
SFRP4 promoter is frequently methylated in this cancer 
leading to inhibition of expression and is associated 
with abnormal growth; restoration of SFRP4 results in 




Tumor-induced osteomalacia is a disorder in which 
there is an increase in renal phosphate excretion and a 
reduction in serum phosphate levels leading to 
hyperphosphaturia, hypophosphatemia and rickets.  
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CLUSTAL alignment of the 5 human SFRPs. 
 
SFRP4 is highly expressed in such tumors and 
functions as a circulating phosphaturic factor that 
antagonizes renal Wnt-signaling. 
Breast Cancer 
Note 
Studies have found evidence for SFRP4 overexpression 
in breast cancer. 
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Pancreatic Cancer 
Note 
SFRP4 found to be significantly hypermethylated in the 




The SFRP4 was highly methylated in gastric carcinoma 




SFRP4 is overexpressed in prostate cancers and 
functions to inhibit cell proliferation and metastatic 
potential. 
Prognosis 
Increased expression of membranous SFRP4 is 
associated with a good prognosis in human localized 
androgen-dependent prostate cancer, suggesting a role 
for sFRP4 in early stage disease. 
B-cell chronic lymphocytic leukemia 
Note 
SFRP4 was found to be frequently methylated and 
downregulated in CLL samples. 
Colorectal Carcinoma 
Note 




SFRP4 mRNA and protein expression were 
significantly decreased due to hypermethylation in 
esophageal adenocarcinoma and Barrett's esophagus 
patients. 
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